News & Insights

5 min read

Antibody Solutions & the COVID-19 Crisis

By Dr. John Kenney on 04/19/2020

EDITOR'S NOTE: We're thankful to be holding true to the potential we outlined in this original April 19 blog post. As part of a collaboration with Single Cell Technology, we've discovered a potential new path for SARS-CoV-2 vaccine and therapy research. We've published our findings in a new paper, and you can get an overview here (as well as a link to the complete research document).


“It must be noted, however, that a single product is unlikely to meet the currently very substantial medical need, and not all product candidates will be successful in clinical studies. Therefore, many initiatives aimed at developing investigational antibodies are needed.”

— Dr. Janice Reichert, executive director, The Antibody Society

Where We Stand Now: The bottom line up-front

It’s probably safe to assume that—for all the wrong reasons—”coronavirus” will be Merriam-Webster’s word of the year for 2020. 

Topics: Insights Pink
1 min read

Webinar: “Using Fluorescence-Activated Cell Sorting (FACS) for B-Cell Isolation”

By Dr. John Kenney on 11/13/2019

Isolating B cells can be a challenging exercise requiring careful planning, precise execution and the right technology. Over the years, the best method that we’ve found to help streamline and improve the efficiency and success of the process is Fluorescence-Activated Cell Sorting (FACS). 

Topics: Insights Pink
5 min read

CAR-T Cell Therapy 101

By Dr. John Kenney on 08/29/2019

Chimeric antigen receptor (CAR-T) cell therapy

A growing number of CAR-T cell therapies are being developed and tested in clinical studies as an innovative approach to reprogram the patient’s immune system to attack its own abnormal cells. For treatment of certain cancers, as well as other diseases, this is a huge leap forward. 

Topics: Insights Pink
4 min read

Climbing for a Crucial Cause - Part 2

By Dr. John Kenney on 07/15/2019

Editor’s Note: Here’s the second installment in a blog post series we’re excited to present in conjunction with our friend and colleague Dr. Oren Beske of ATUM. If you missed Oren’s first post on his climb to help the Fred Hutchinson Cancer Research Center, you can read it here.

Thanks for continuing this journey with us. Onward and, more importantly, upward!

John Kenney

Co-Founder and CEO, Antibody Solutions

Topics: Insights Pink
1 min read

Success Rate of Different Antibody Platforms for Drug Discovery

By Dr. John Kenney on 03/07/2019

We are occasionally asked about the success rate of different antibody platforms for drug discovery. There are a variety of technologies available for therapeutic antibody discovery: conventional mice where the Abs are humanized, human Ab transgenic rodents, human Ab synthetic phage and yeast libraries, and others.

Topics: Insights Pink
1 min read

CAR-TCR Summit 2019

By Marketing on 03/07/2019

Antibody Solutions will be attending CAR-TCR Summit 2019, to be held September 10-13 in Boston, MA.

Topics: Events Pink

Antibody Solutions News & Insights